TCL Archive Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent January 8, 1982
TCL Archive FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer September 24, 1999